Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis

To assess the effects of finerenone and glucagon-like peptide 1 receptor agonists (GLP1-RA) on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus (T2DM), and the relative cardiovascula...

Source: Diabetology and Metabolic Syndrome - January 11, 2024 Category: Endocrinology Authors: Xia Gu, Shimin Jiang, Yue Yang and Wenge Li Tags: Research Source Type: research